Live Breaking News & Updates on Biologically Active Copolymer

Stay updated with breaking news from Biologically active copolymer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Recce Pharmaceuticals Granted New Anti-Viral Patent in Australia for RECCE® Anti-Infectives

SYDNEY, Australia, Aug. 04, 2023 (GLOBE NEWSWIRE) Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q), the Company developing a new class of synthetic anti-infectives, is pleased to announce the Australian Patent Office has formally granted Recce a new family four patent, “Process for Preparation of Biologically Active Copolymer,” with expiry in 2041. “We are thrilled to receive this new family of intellectual property, granted by the Australian Patent Office, with further market monopolies reinfo ....

United States , Cross River , New South Wales , Andrew Geddes , Jordyn Temperato , James Graham , Australian Patent Office , Recce Pharmaceuticals , Lifesci Communications , Recce Pharmaceuticals Ltd , Pharmaceuticals Ltd , Biologically Active Copolymer , Chief Executive Officer , Australian Patent , Patent Cooperation Treaty Country , Pathogens Covered , Varicella Zoster Virus , New Class , Synthetic Anti Infectives , Infectious Disease Product , Generating Antibiotic Initiatives Now , Fast Track Designation , Pew Charitable Trusts Global New Antibiotics , Development Pipeline , Investor Relations , Bacterial Infections ,

Recce Pharmaceuticals Ltd further strengthens market monopoly for anti-infectives

Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF) CEO James Graham tells Proactive that the company has been given a boost from the Australian Patent Office,. ....

James Graham , Recce Pharmaceuticals Ltd , Australian Patent Office , Patent Family , Biologically Active Copolymer ,

Recce Pharmaceuticals Ltd welcomes 'intent to grant' Family 4 patent for anti-infectives

Recce Pharmaceuticals Ltd welcomes 'intent to grant' Family 4 patent for anti-infectives
proactiveinvestors.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.co.uk Daily Mail and Mail on Sunday newspapers.

Cross River , James Graham , Recce Pharmaceuticals Ltd , Australian Patent Office , Patent Family , Biologically Active Copolymer , Australian Patent , Patent Cooperation Treaty Country , Varicella Zoster Virus ,

Recce Pharmaceuticals further strengthens market monopoly for anti-infectives

Recce Pharmaceuticals Ltd CEO James Graham tells Proactive that the company has been given a boost from the Australian Patent Office, which has issued notification of ‘intent to grant’. | April 11, 2023 ....

James Graham , Jonathan Jackson , Recce Pharmaceuticals Ltd , Australian Patent Office , Pharmaceuticals Ltd , Patent Family , Biologically Active Copolymer , Recce Pharmaceuticals Ltd Stock Exchange , Press Release , O Rce Au000000rce5 ,